HEART VALVE DISEASES
Clinical trials for HEART VALVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEART VALVE DISEASES trials appear
Sign up with your email to follow new studies for HEART VALVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve implant offers hope for High-Risk patients
Disease control OngoingThis study tested a new device called the Tendyne Transcatheter Mitral Valve System. It is designed for people with a serious leak in their mitral heart valve (mitral regurgitation) who are too sick or high-risk for traditional open-heart surgery. The trial compared the new Tendy…
Matched conditions: HEART VALVE DISEASES
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New heart valve implant aims to fix severe leak, improve lives
Disease control OngoingThis trial is testing a new device called the Edwards EVOQUE system, which is implanted via a catheter to replace a leaky tricuspid heart valve. It aims to see if this implant, along with standard medication, is safer and more effective than medication alone for patients with sev…
Matched conditions: HEART VALVE DISEASES
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New heart valve offers hope for safer, less invasive treatment
Disease control ENROLLING_BY_INVITATIONThis study is testing a new device called the Navitor valve, which is designed to replace a narrowed aortic heart valve without major open-heart surgery. It will enroll about 1,500 people with severe, symptomatic aortic stenosis who are considered at low or intermediate risk for …
Matched conditions: HEART VALVE DISEASES
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Heart valve patients could go home in just one day
Disease control OngoingThis study is testing whether it is safe and effective for patients to be discharged from the hospital just 24 hours after a TAVI procedure, a minimally invasive heart valve replacement. It involves 585 adults with aortic valve disease who are having the procedure done through th…
Matched conditions: HEART VALVE DISEASES
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New heart valve procedure tested to fix deadly leaks without major surgery
Disease control OngoingThis study is testing a new device called the EVOQUE system, which is designed to replace a leaky tricuspid heart valve using a catheter inserted through a blood vessel, avoiding open-heart surgery. The trial aims to see if this procedure is safe and effective at reducing severe …
Matched conditions: HEART VALVE DISEASES
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC